During Covid, Tim Walz rationed access to monoclonal antibody treatments based on skin color. Being non-white gave a person more priority than having hypertension, and was equal in importance to having massive risk factors like diabetes or cardiovascular disease.
The notion that access to the treatments was rationed by race and that may have led to the deaths of white people is false and ignores key details about Minnesota's policy, experts told PolitiFact.
To account for that, Minnesota developed a scoring system that factored in race to determine who would be prioritized for the antibody treatments. This system was in effect for about one month of the program's 16-month duration.
The Minnesota Department of Health said the Food and Drug Administration acknowledged that race and ethnicity may also place individual patients at high risk for progression to severe COVID-19.
Collection
[
|
...
]